Important Safety Information
This summary contains important information about Ribasphere® (Rīb-ă-sphere) (ribavirin, USP) tablets. It is not meant to take the place of your doctor’s and/or healthcare provider’s instructions. Read this information carefully before you start taking Ribasphere tablets. Ask your doctor and/or healthcare provider if you do not understand any of this information, or if you want to know more about Ribasphere tablets. Read the Medication Guide given to you for Ribasphere tablets. Also read the Medication Guide for PEGASYS®1 (peginterferon alfa-2a).
WARNING: RISK OF SERIOUS DISORDERS AND RIBASPHERE (RIBAVIRIN, USP) TABLETS - ASSOCIATED EFFECTS
See full Prescribing Information for complete boxed warning
- You should not take Ribasphere tablets alone to treat chronic hepatitis C infection.
- Ribasphere tablets may cause you to have a blood problem (hemolytic anemia) that can worsen any heart problems you have, and cause you to have a heart attack or die. People with a history of serious heart disease should not be treated with this medicine. Please talk to your health care professional to see if this medicine is right for you.
- Ribasphere tablets may cause birth defects or death of your unborn baby. You should not take Ribasphere tablets if you are pregnant or your sexual partner is pregnant, nor should you or your partner become pregnant while you are taking Ribasphere tablets and for 6 months after you stop treatment. You need to use two forms of reliable birth control when you take Ribasphere tablets and for the 6 months after treatment.
What are Ribasphere (ribavirin, USP) Tablets?
Ribasphere (ribavirin, USP) tablets are used in combination with another medicine called peginterferon alfa-2a to treat chronic (lasting a long time) hepatitis C infection (CHC) in people whose livers still work normally, and who have not been treated before with a medicine called an interferon alpha. This combination is also used to treat CHC patients coinfected with human immunodeficiency virus (HIV). It is not known if Ribasphere tablets are safe and will work in children under 18 years of age.
Who Should Not Take Ribasphere Tablets?
Do not take Ribasphere tablets if you:
- have certain types of hepatitis caused by your immune system attacking your liver (autoimmune hepatitis);
- have certain blood disorders, such as thalassemia major or sickle-cell anemia (hemoglobinopathies);
- have severe kidney disease; or
- take didanosine (Videx®2 or Videx EC®)
Important Information about Ribasphere Tablets:
- You should not take Ribasphere tablets alone to treat chronic hepatitis C infection. Ribasphere tablets should be used in combination with peginterferon alfa-2a to treat chronic hepatitis C infection.
- Ribasphere tablets may cause you to have a blood problem (hemolytic anemia) that can worsen any heart problems you have, and cause you to have a heart attack or die. Tell your healthcare provider if you have ever had any heart problems. Ribasphere tablets may not be right for you. If you have chest pain while you take Ribasphere tablets, seek emergency medical attention right away.
- Ribasphere tablets may cause birth defects or death of your unborn baby. Do not take Ribasphere tablets if you are pregnant, or planning to get pregnant during treatment or during the 6 months after treatment. Do not take Ribasphere tablets if you are a male patient with a female sexual partner who is pregnant or plans to become pregnant at any time while you are being treated with ribavirin or during the 6 months after your treatment has ended. You must use two forms of birth control when you are taking Ribasphere tablets and for the 6 months following the treatment’s completion.
- Females must have a pregnancy test before beginning a treatment regime which includes Ribasphere tablets, in addition to every month thereafter while being treated with Ribasphere tablets and every month for 6 months following the treatment’s completion.
- If you or your sexual partner becomes pregnant while taking Ribasphere tablets or within 6 months after you stop taking Ribasphere tablets, tell your healthcare provider right away. You or your healthcare provider should contact the Ribavirin Pregnancy Registry by calling 1-800-593-2214. The Ribavirin Pregnancy Registry collects information about what happens to mothers and their babies if the mother takes, or is exposed to, Ribasphere tablets while she is pregnant.
What Are the Possible Side Effects of Ribasphere Tablets?
Ribasphere tablets can cause serious side effects including:
- swelling and irritation of your pancreas (pancreatitis). You may have stomach pain, nausea, vomiting or diarrhea;
- severe allergic reactions: Symptoms may include hives, wheezing, trouble breathing, chest pain, swelling of your mouth, tongue, or lips, or severe rash;
- serious breathing problems: Difficulty breathing may be a sign of a serious lung infection (pneumonia) that can lead to death;
- serious eye problems: Which could lead to vision loss or blindness;
- liver problems: Some people may get worsening of liver function. Tell your healthcare provider right away if you have any of these symptoms: stomach bloating, confusion, brown urine and yellow eyes;
- severe depression; and/or
- suicidal thoughts and attempts.
Call your healthcare provider or get medical help right away if you have any of the symptoms listed above. These may be signs of a serious side effect of Ribasphere tablets treatment.
Common side effects of Ribasphere tablets used in combination with peginterferon alfa-2a include:
- flu-like symptoms (for example: feeling tired, headache, shaking along with high temperature (fever), and muscle or joint aches);
- mood changes, feeling irritable, anxiety and difficulty sleeping;
- loss of appetite, nausea, vomiting and diarrhea;
- hair loss; and/or
Before You Take Ribasphere Tablets, Tell Your Healthcare Provider if You Are, Have, or Have Had:
- treatment for hepatitis C that did not work for you;
- serious allergic reactions to Ribasphere tablets, or to any of the ingredients in Ribasphere tablets;
- breathing problems (Ribasphere tablets may cause or worsen your breathing problems you already have.);
- vision problems (Ribasphere tablets may cause eye problems or worsen eye problems you already have. You should have an eye exam before you start treatment with Ribasphere tablets.);
- certain blood disorders such as anemia;
- high blood pressure, heart problems or have had a heart attack (Your healthcare provider should test your blood and heart before you start treatment with Ribasphere tablets.);
- thyroid problems;
- diabetes (Ribasphere tablets and peginterferon alfa-2a combination therapy may make your diabetes worse or harder to treat.);
- liver problems other than hepatitis C virus infection;
- human immunodeficiency virus (HIV) or other immunity problems;
- mental health problems, including depression or thoughts of suicide;
- kidney problems;
- an organ transplant;
- drug addiction or abuse;
- infection with the hepatitis B virus;
- breast-feeding (It is not known if Ribasphere tablets passes into
your breast milk. You and your healthcare provider should decide if you will take
Ribasphere tablets or breast-feed.); and/or
- any other medical condition.
How should you take Ribasphere tablets?
- Take Ribasphere tablets exactly as your healthcare provider tells you. Your healthcare provider will tell you how much Ribasphere tablets to take and when to take it.
- Take Ribasphere tablets with food.
- If you miss a dose of Ribasphere tablets, take the missed dose as soon as possible during the same day. Do not double the next dose. If you have questions about what to do, call your healthcare provider.
- If you take too much Ribasphere tablets, call your healthcare provider or local Poison Control Center right away, or go to the nearest hospital emergency room right away.
- Your healthcare provider should do blood tests before you start treatment with Ribasphere tablets, at weeks 2 and 4 of treatment, and then as needed to see how well you are tolerating treatment and to check for side effects. Your healthcare provider may change your dose of Ribasphere tablets based on blood test results or side effects you may have.
- If you have heart problems, your healthcare provider should check your heart by doing an electrocardiogram before you start treatment with Ribasphere tablets, and if needed during treatment.
What should you avoid while taking Ribasphere tablets?
- Ribasphere tablets can make you feel tired, dizzy or confused. You should not drive or operate machinery if you have any of these symptoms.
- Do not drink alcohol, including beer, wine and liquor. This may make your liver disease worse.
Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins and herbal supplements. Some medicines can cause serious side effects if taken while you also take Ribasphere tablets. Some medicines may affect how Ribasphere tablets work or Ribasphere tablets may affect how your other medicines work. Especially tell your healthcare provider if you take any medicines to treat HIV, including didanosine (Videx®2 or Videx EC®), or if you take azathioprine (Imuran®3 or Azasan®4).
Talk to your healthcare provider before starting treatment with Ribasphere tablets if you have any of these medical conditions.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see Ribasphere tablets full Prescribing Information and Medication Guide, including boxed warning, for additional Important Safety Information. Visit www.ribapak.com, or call 1-877-377-7862.
Issued: July 2014 Item No.: C130.00125
Copyright © 2014 by Kadmon Pharmaceuticals, LLC. All rights reserved.
- PEGASYS® is a registered trademark of Hoffmann-La Roche Inc.
- Videx® is a registered trademark of Bristol-Myers Squibb Company
- Imuran® is a registered trademark of Prometheus Laboratories, Inc.
- Azasan® is a registered trademark of Salix Pharmaceuticals, Inc.
*Eligible patients may save up to $150 toward each monthly Ribasphere RibaPak copay for up to eighteen (18) fills. The Ribasphere RibaPak CoPay Savings Card is available for self-pay patients and most commercially insured patients except those residing in Massachusetts and Puerto Rico. Patients covered by Medicare, Medicaid, TRICARE or other federal or state healthcare programs are not eligible. Patients must be eighteen (18) years of age or older to participate. The CoPay Savings Card is valid for Ribasphere RibaPak product only. Only one (1) CoPay Savings Card is required per patient. If denied copay card savings, patients may be eligible to receive a discount directly from Opus Health through its Mail-in Rebate Program by calling the phone number provided on the card.